Peak drug names: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
It is related to the distinct concept of drug name depletion; while global drug name reserves are finite, the limiting factor is not whether the drug names but whether pharmaceutical manufacturers and distribution cartels profit by the names. | It is related to the distinct concept of drug name depletion; while global drug name reserves are finite, the limiting factor is not whether the drug names but whether pharmaceutical manufacturers and distribution cartels profit by the names. | ||
== Advertisement == | |||
New drugs. New names. | |||
Ask your etymologist if new drugs are right for you. | |||
== In the News == | == In the News == | ||
Revision as of 19:38, 18 October 2022
Peak drug names is the moment at which economically viable production of names for new drugs starts to decrease.
It is related to the distinct concept of drug name depletion; while global drug name reserves are finite, the limiting factor is not whether the drug names but whether pharmaceutical manufacturers and distribution cartels profit by the names.
Advertisement
New drugs. New names.
Ask your etymologist if new drugs are right for you.
In the News
Fiction cross-reference
Nonfiction cross-reference
External links
- [ Post] @ Twitter (18 October 2022)
- [] @ Wikipedia
- [] @ Wikipedia
- @ YouTube
- @ YouTube